Von Willebrand factor is an independent predictor of short‐term mortality in acutely ill patients with cirrhosis

Abstract

AbstractBackground and AimsLevels of von Willebrand factor (VWF) are elevated in patients with cirrhosis, and correlate well with disease severity. In patients with decompensated cirrhosis (DC), plasma VWF is associated with mortality. The value of VWF in predicting short‐term mortality risk in patients with acute‐on‐chronic liver failure (ACLF) is, however, unclear.MethodsWe included patients with DC (n = 111) and ACLF (n = 105). We measured VWF levels and correlated these with other laboratory parameters and prediction models for mortality. Also, we assessed the predictive value of VWF in the prediction of 90‐ and 30‐day mortality in patients with DC and ACLF, respectively, and compared this to the predictive value of clinically used prediction models. Finally, we determined the optimal cut‐off value for VWF in patients with ACLF.ResultsSixteen of 111 (14%) patients with DC and 35 of 105 (33%) with ACLF died within 90 and 30 days, respectively. VWF was associated with mortality and correlated closely with other prediction models. In patients with ACLF, VWF levels had a discrimination for 30‐day mortality comparable with these models and accurately identified ACLF patients with high 30‐day mortality risk.ConclusionsLevels of VWF associate closely with risk of mortality in patients with DC and ACLF, and may have predictive utility as a laboratory marker of prognosis. Further research is warranted to assess the additional value of VWF in the prediction of mortality and associated complications in chronic liver failure syndromes.